American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

Pushback against Trump's $100K visa fee continues with new lawsuit
As a new lawsuit targets the unpopular policy, the American College of Cardiology and other medical societies worry that $100,000 fees will make the ongoing physician shortage much worse.
ACC urges Congress to restore telemedicine flexibilities
The American College of Cardiology, like many other U.S. medical societies, is fighting to bring back telehealth policies that expired at the end of September.
DAPT during valve-in-valve TAVR may reduce stroke risk—more data still required
New research suggests there may be a cardiovascular benefit to considering dual antiplatelet therapy for valve-in-valve TAVR patients.
Trump's $100K visa fee will be bad for heart patients
"There is already a deficit of doctors in the U.S., and this will make it worse," one cardiologist told Cardiovascular Business. Medical societies throughout the country seem to agree.
ACC calls for more screening in new scientific statement on inflammation
The document provides an in-depth look at the close relationship between inflammation and cardiovascular disease. "The time for taking action has now arrived," the authors wrote.

Pushback against Trump's $100K visa fee continues with new lawsuit

As a new lawsuit targets the unpopular policy, the American College of Cardiology and other medical societies worry that $100,000 fees will make the ongoing physician shortage much worse.

ACC urges Congress to restore telemedicine flexibilities

The American College of Cardiology, like many other U.S. medical societies, is fighting to bring back telehealth policies that expired at the end of September.

DAPT during valve-in-valve TAVR may reduce stroke risk—more data still required

New research suggests there may be a cardiovascular benefit to considering dual antiplatelet therapy for valve-in-valve TAVR patients.

President Trump's presidential proclamation Sept. 19 to implement a $100,000 fee for H-1B visa applications had immediate backlash from dozens of medical societies. Groups like the American Medical Association (AMA) and the American College of Cardiology (ACC) said this will cut off the flow of foreign physicians into the U.S. at a time when we cannot graduate enough American physicians to fill positions in a healthcare system that is facing a rapidly growing physician shortage.

Trump's $100K visa fee will be bad for heart patients

"There is already a deficit of doctors in the U.S., and this will make it worse," one cardiologist told Cardiovascular Business. Medical societies throughout the country seem to agree.

A new ACC consensus document of coronary inflammation calls for wider use of hs-CRP testing to identify more patients with residual heart attack risk, even if they are optimal statin therapy.

ACC calls for more screening in new scientific statement on inflammation

The document provides an in-depth look at the close relationship between inflammation and cardiovascular disease. "The time for taking action has now arrived," the authors wrote.

ACC and AHA outline calculation of cost-effectiveness in clinical practice guidelines

Healthcare's cost-conscious environment prompted the ACC and AHA to develop a statement on the value methodology to be used when creating clinical practice guidelines.

Vulnerable, but treatable: Semaglutide reduces symptoms in high-risk heart failure patients

Yes, even frail HFpEF patients see significant benefits when treated with semaglutide. Researchers believe these new data may help ease the minds of cardiologists everywhere.

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

CVD responsible for 1 in 3 deaths around the world

Cardiovascular disease remains the world’s leading cause of death, according to a special report from the American College of Cardiology. The new analysis, described by one cardiologist as a "wake-up call," includes data from more than 200 countries and territories.